Sangamo Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
31.12.24
/
50%
€1.00
Target price
31.12.25
€2.90
Performance (%)
-62.40%
Price
15.12.25
€0.38
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ for Sangamo Therapeutics Inc. is performing very badly with a performance of -62.40%. This prediction currently runs until 31.12.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sangamo Therapeutics Inc. | -13.244% | -13.244% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by Jefferies_Financial_ for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Jefferies Financial Group Inc. from $7.00 to $3.00. They now have a "buy" rating on the stock.
Ratings data for SGMO provided by MarketBeat